Evidence map›Paper›PMID 34944072›Full record

ArticleCells2021

Differences in Cell-Intrinsic Inflammatory Programs of Yolk Sac and Bone Marrow Macrophages.

Sara Elhag, Christopher Stremmel, Annette Zehrer, Josefine Plocke, Roman Hennel, Michaela Keuper, Clarissa Knabe, Julia Winterhalter, Vanessa Gölling, Lukas Tomas and 15 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Macrophages in Atheromatous Plaque Developmental Stages.Frontiers in cardiovascular medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 3 countries.

Sara ElhagMedizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität, 81377 Munich, Germany.
Christopher StremmelMedizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität, 81377 Munich, Germany.
Annette ZehrerBiomedical Center, Institute of Cardiovascular Physiology and Pathophysiology, Ludwig-Maximilians-University Munich, Planegg-Martinsried, 82152 Munich, Germany.
Josefine PlockeDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, 17475 Greifswald, Germany.
Roman HennelDepartment of Radiation Oncology, LMU Klinikum, Ludwig-Maximilians-Universität, 81377 Munich, Germany.
Michaela KeuperDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 106 91 Stockholm, Sweden.
Clarissa KnabeMedizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität, 81377 Munich, Germany.
Julia WinterhalterMedizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität, 81377 Munich, Germany.
Vanessa GöllingInstitute of Experimental Hematology, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
Lukas TomasMedizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität, 81377 Munich, Germany.
Tobias WeinbergerMedizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität, 81377 Munich, Germany.
Maximilian FischerMedizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität, 81377 Munich, Germany.ORCID 0000-0001-9172-3316
Lulu LiuMedizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität, 81377 Munich, Germany.
Franziska WagnerMedizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität, 81377 Munich, Germany.
Michael LorenzMedizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität, 81377 Munich, Germany.
Konstantin StarkMedizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität, 81377 Munich, Germany.
Hans HäckerDivision of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA.
Marc Schmidt-SupprianInstitute of Experimental Hematology, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
Uwe VölkerDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-5689-3448
Martin JastrochDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 106 91 Stockholm, Sweden.
Kirsten LauberDepartment of Radiation Oncology, LMU Klinikum, Ludwig-Maximilians-Universität, 81377 Munich, Germany.
Tobias StraubCore Facility Bioinformatics, Biomedical Center, Ludwig-Maximilians-University Munich, Planegg-Martinsried, 82152 Munich, Germany.
Barbara WalzogBiomedical Center, Institute of Cardiovascular Physiology and Pathophysiology, Ludwig-Maximilians-University Munich, Planegg-Martinsried, 82152 Munich, Germany.
Elke HammerDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-1507-0402
Christian SchulzMedizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität, 81377 Munich, Germany.ORCID 0000-0002-8149-0747
LMU Klinikum · DEUniversitätsmedizin Greifswald · DEStockholm University · SETechnical University of Munich · DELudwig-Maximilians-Universität München · DEUniversity of Utah · US

Funding

Deutsche Forschungsgemeinschaft SFB 914, project A10German Centre for Cardiovascular Research 81X2600246
6 · The paper itself

Abstract

backgroundTissue-resident macrophages have mixed developmental origins. They derive in variable extent from yolk sac (YS) hematopoiesis during embryonic development. Bone marrow (BM) hematopoietic progenitors give rise to tissue macrophages in postnatal life, and their contribution increases upon organ injury. Since the phenotype and functions of macrophages are modulated by the tissue of residence, the impact of their origin and developmental paths has remained incompletely understood.

methodsIn order to decipher cell-intrinsic macrophage programs, we immortalized hematopoietic progenitors from YS and BM using conditional HoxB8, and carried out an in-depth functional and molecular analysis of differentiated macrophages.

resultsWhile YS and BM macrophages demonstrate close similarities in terms of cellular growth, differentiation, cell death susceptibility and phagocytic properties, they display differences in cell metabolism, expression of inflammatory markers and inflammasome activation. Reduced abundance of PYCARD (ASC) and CASPASE-1 proteins in YS macrophages abrogated interleukin-1β production in response to canonical and non-canonical inflammasome activation.

conclusionsMacrophage ontogeny is associated with distinct cellular programs and immune response. Our findings contribute to the understanding of the regulation and programming of macrophage functions.

Indexed as

AnimalsBone MarrowCell DifferentiationCell ProliferationGene Expression ProfilingGene Expression RegulationGlycolysisHEK293 CellsHematopoietic Stem CellsHomeodomain ProteinsHumansInflammasomesInflammationMacrophagesMiceMice, Inbred C57BLHomeodomain ProteinsHoxb8 protein, mouseInflammasomesProteomeProto-Oncogene Proteins c-kitinflammasomemacrophagesyolk sac

Identifiers

PMID34944072
PMCPMC8699930
OpenAlexW4200607094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.